Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 11/20 | 0.58 |
| ▸ | CASP9 | P55211 | 1/20 | 0.58 |
| ▸ | BIRC2 | Q13490 | 16/20 | 0.58 |
| ▸ | BIRC3 | Q13489 | 7/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8514532 | 0.91 | BIRC2 (0.60) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL4315737 | 0.89 | XIAP (0.70) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL30249738 | 0.89 | XIAP (0.70) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL14421200 | 0.89 | XIAP (0.70) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL14421116 | 0.89 | XIAP (0.70) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL4562933 | 0.86 | BIRC2 (0.56) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL13260011 | 0.86 | XIAP (0.58) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL9609042 | 0.86 | XIAP (0.58) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL3728566 | 0.85 | XIAP (0.59) | XIAPCASP9BIRC2BIRC3 | |
| SCHEMBL13260010 | 0.85 | XIAP (0.59) | XIAPCASP9BIRC2BIRC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190688-A1 | Tetrapeptide analogs | IDUN PHARMACEUTICALS, INC. | 2010-07-29 | — | — | US | disclosed |
| US-20100190688-A1 | Tetrapeptide analogs | IDUN PHARMACEUTICALS, INC. | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190688-A1 | Tetrapeptide analogs | TP53, PCNA, HRAS | XIAP 141/4885CASP9 2341/4885BIRC2 259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.